Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
Posted: 29 Jul 2009
Date Written: August 2009
Abstract
This article demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.
Suggested Citation: Suggested Citation
Athreye, Suma S. and Kale, Dinar and Ramani, Shyama, Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector (August 2009). Industrial and Corporate Change, Vol. 18, Issue 4, pp. 729-759, 2009, Available at SSRN: https://ssrn.com/abstract=1440070 or http://dx.doi.org/dtp024
Feedback
Feedback to SSRN